These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23815861)

  • 21. Contemporary burden of illness of congestive heart failure in Canada.
    Tsuyuki RT; Shibata MC; Nilsson C; Hervas-Malo M
    Can J Cardiol; 2003 Mar; 19(4):436-8. PubMed ID: 12704492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?
    Tomaszuk-Kazberuk A; Kozuch M; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Musial WJ
    Ren Fail; 2013; 35(2):235-42. PubMed ID: 23176538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 'real' woman with heart failure. Impact of sex on current in-hospital management of heart failure by cardiologists and internists.
    Opasich C; De Feo S; Ambrosio GA; Bellis P; Di Lenarda A; Di Tano G; Fico D; Gonzini L; Lavecchia R; Tomasi C; Maggioni AP;
    Eur J Heart Fail; 2004 Oct; 6(6):769-79. PubMed ID: 15542415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
    Kárpáti P
    Orv Hetil; 2005 May; 146(18):827-31. PubMed ID: 15926627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHF disease management programs produce dramatic shift away from hospitalization.
    Healthc Demand Dis Manag; 1998 Jan; 4(1):7-10. PubMed ID: 10177380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring quality in heart failure: do we have the metrics?
    Bonow RO
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):9-11. PubMed ID: 20031782
    [No Abstract]   [Full Text] [Related]  

  • 28. [Heart failure in Eastern Veneto: prevalence, hospitalization rate, adherence to guidelines and social costs].
    Valle R; Baccichetto R; Barro S; Calderan A; Carbonieri E; Chinellato M; Chiatto M; D'Eri A; Corazza F; D'Atri M; Drigo R; Fabris S; Gelli GF; Lo Giudice A; Noventa F; Pollon A; Santin P; Zanardi F; Milani L
    Monaldi Arch Chest Dis; 2006 Mar; 66(1):63-74. PubMed ID: 17125047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of angiotensin II receptor antagonists as a novel drug for the treatment of chronic heart failure--in comparison with ACE inhibitors].
    Kitakaze M; Kuzuya T; Hori M
    Nihon Rinsho; 1999 May; 57(5):1148-57. PubMed ID: 10361449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivabradine reduces total hospital burden in heart failure.
    Aalbers J
    Cardiovasc J Afr; 2012 Oct; 23(9):528. PubMed ID: 23108523
    [No Abstract]   [Full Text] [Related]  

  • 31. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme.
    de Groote P; Isnard R; Clerson P; Jondeau G; Galinier M; Assyag P; Demil N; Ducardonnet A; Thebaut JF; Komajda M
    Eur J Heart Fail; 2009 Jan; 11(1):85-91. PubMed ID: 19147461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiologic evaluation of cardiac decompensation and its impact on health costs].
    Bilora F; Vettore G; Saccaro G; Barbata A; Dei Rossi C; Petrobelli F
    Minerva Cardioangiol; 1998; 46(7-8):235-9. PubMed ID: 9973786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
    Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
    Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
    J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and 1 year outcome of oldest-old hospitalized heart failure patients: a subacute geriatric hospital survey.
    Vigder C; Ben Israel Y; Meisel SR; Kaykov E; Gottlieb S; Shotan A
    Isr Med Assoc J; 2010 Aug; 12(8):483-8. PubMed ID: 21337817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cost of acute heart failure related readmissions].
    Ríhová B; Parenica J; Miklík R; Felsöci M; Horáková K; Sulcová A; Jarkovsý J; Spinar J
    Vnitr Lek; 2011 Oct; 57(10):803-7. PubMed ID: 22097687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of angiotensin-converting enzyme inhibitors in the treatment of congestive heart failure.
    Tu K; Mamdani M; Kopp A; Lee D
    Am J Cardiol; 2005 Jan; 95(2):283-6. PubMed ID: 15642572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
    Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF;
    Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.